Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573787
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste DisordersChristoph GrimmTerminatedNot Applicable
NCT07573787Terminated
Not Applicable
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste Dis...Christoph Grimm
NCT07572721
Virtual Lifestyle Intervention for Weight Management and Cardiovascular HealTruemedicine IncEnrolling By InvitationNot Applicable
NCT07572721Enrolling By Invitation
Not Applicable
Virtual Lifestyle Intervention for Weight Management and Cardiovascular HealTruemedicine Inc
NCT07572214
Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)Alder Hey Children's NHS Foundation TrustCompleted
NCT07572214Completed
—
Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)Alder Hey Children's NHS...
NCT07573293
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional AthletesCairo UniversityCompletedNot Applicable
NCT07573293Completed
Not Applicable
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional Athlet...Cairo University
NCT07573891
Combined Effect of FES And FCT in Cerebral PalsyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07573891Not Yet Recruiting
Not Applicable
Combined Effect of FES And FCT in Cerebral PalsyRiphah International Univ...
NCT07573254
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With Mechanical Low Back PainIstinye UniversityCompletedNot Applicable
NCT07573254Completed
Not Applicable
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational...Istinye University
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
NCT07573410
Effects of Mindful Eating on Female Nutrition StudentsFederal University of UberlandiaNot Yet RecruitingNot Applicable
NCT07573410Not Yet Recruiting
Not Applicable
Effects of Mindful Eating on Female Nutrition StudentsFederal University of Ube...
NCT07573735
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic DermatitisZhongda HospitalRecruiting
NCT07573735Recruiting
—
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Derm...Zhongda Hospital
NCT07573475
The Effect of tDCS Combined With TMS on Cognitive Impairment and Motor Function After StrokeKe Dong, MDNot Yet RecruitingNot Applicable
NCT07573475Not Yet Recruiting
Not Applicable
The Effect of tDCS Combined With TMS on Cognitive Impairment and Motor Function...Ke Dong, MD
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574034
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction SyndromeGregor AndelfingerNot Yet RecruitingNot Applicable
NCT07574034Not Yet Recruiting
Not Applicable
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction...Gregor Andelfinger
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLCNot Yet RecruitingPhase 1
NCT07572006Not Yet Recruiting
Phase 1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Develo...
Result Breakdown
Not yet recruiting9 (45%)
Completed5 (25%)
Enrolling by invitation2 (10%)
Recruiting2 (10%)
Terminated1 (5%)
Withdrawn1 (5%)
not_applicable11 (55%)
Not Specified5 (25%)
Phase 12 (10%)
Phase 21 (5%)
Phase 41 (5%)